Efficient siRNA delivery with non-viral polymeric vehicles.
about
RNA interference-based nanosystems for inflammatory bowel disease therapyAffinity-Based Drug DeliveryCombinatorial approach to determine functional group effects on lipidoid-mediated siRNA delivery.Use of Nanotechnology to Develop Multi-Drug Inhibitors For Cancer TherapySynthesis and characterization of mannosylated pegylated polyethylenimine as a carrier for siRNA.Bioreducible polymers for therapeutic gene deliverySuppression of lung cancer progression by biocompatible glycerol triacrylate-spermine-mediated delivery of shAkt1.Innovative strategy for microRNA delivery in human mesenchymal stem cells via magnetic nanoparticles.Co-delivery of small interfering RNA and plasmid DNA using a polymeric vector incorporating endosomolytic oligomeric sulfonamide.EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex.Codelivery of DNA and siRNA via arginine-rich PEI-based polyplexes.Biodegradation, biocompatibility, and drug delivery in poly(ω-pentadecalactone-co-p-dioxanone) copolyestersEnhanced delivery of PEAL nanoparticles with ultrasound targeted microbubble destruction mediated siRNA transfection in human MCF-7/S and MCF-7/ADR cells in vitro.Second Generation Amphiphilic Poly-Lysine Dendrons Inhibit Glioblastoma Cell Proliferation without Toxicity for Neurons or AstrocytesIntra-articular controlled release of anti-inflammatory siRNA with biodegradable polymer microparticles ameliorates temporomandibular joint inflammationPolymeric nucleic acid carriers: current issues and novel design approachesFunctionalized, biodegradable hydrogels for control over sustained and localized siRNA delivery to incorporated and surrounding cells.Toward personalized cancer nanomedicine - past, present, and future.Photocleavable Hydrogels for Light-Triggered siRNA Release.Novel polymer micelle mediated co-delivery of doxorubicin and P-glycoprotein siRNA for reversal of multidrug resistance and synergistic tumor therapy.Redox-based control of the transformation and activation of siRNA complexes in extracellular environments using ferrocenyl lipids.Plasmid-based Stat3 siRNA delivered by hydroxyapatite nanoparticles suppresses mouse prostate tumour growth in vivo.Comparison of anti-EGFR-Fab' conjugated immunoliposomes modified with two different conjugation linkers for siRNa delivery in SMMC-7721 cellsThermo-/pH-dual responsive properties of hyperbranched polyethylenimine grafted by phenylalanine.Progress in microRNA delivery.Degradable Dextran Nanopolymer as a Carrier for Choline Kinase (ChoK) siRNA Cancer Therapy.siRNA applications in nanomedicineSmart siRNA delivery systems based on polymeric nanoassemblies and nanoparticles.siRNA therapy for cancer and non-lethal diseases such as arthritis and osteoporosis.Research progress on siRNA delivery with nonviral carriers.Polymers in small-interfering RNA deliveryExosome mimetics: a novel class of drug delivery systems.Current status of gene delivery: spotlight on nanomaterial-polymer hybrids.Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy.Polyethylenimine and chitosan carriers for the delivery of RNA interference effectors.Functional polymers of gene delivery for treatment of myocardial infarct.Nanotechnology Approaches for the Delivery of Exogenous siRNA for HIV Therapy.Multivalent aptamer-RNA based fluorescent probes for carrier-free detection of cellular microRNA-34a in mucin1-expressing cancer cells.Chitosan combined with molecular beacon for mir-155 detection and imaging in lung cancer.Hydrogel doped with nanoparticles for local sustained release of siRNA in breast cancer.
P2860
Q28071518-079F23EF-C155-4CFA-B163-1CC4F8AD0D05Q29543246-88219C7D-A47C-41F1-99E7-D54347A430C1Q33660805-DDB2E844-5C5B-41A7-9F91-7A4BEB9A38D5Q33859472-2C9FCE54-2AB0-48DB-9490-073D2BF0E559Q34001975-4EEEFB27-F901-422B-84D8-3DE4E1CD4773Q34079568-10D09D09-BAE9-44A4-B423-69F77BBC6157Q34278743-C6EBE06F-2174-4BDE-AEA8-7DC4A5295446Q34736652-D2B19F0C-3EE3-46B0-8FCC-722F58435113Q34984827-7D285F67-2665-4774-9DA0-0C29D0F21950Q35018628-17DA7A7C-F921-49BA-BBF3-4628BE88EC2FQ35040420-777F5CCC-2324-4000-9D34-E65644C96AEDQ35097957-7D765109-E088-484E-90B2-789AF38A758DQ36015938-F15283A0-6E04-4598-99E2-3F2E6B189360Q36188526-DEDC3BDB-D475-4A6C-BB02-018ABFF86CF4Q36194976-FFF3BADB-D3DD-4793-A342-A64FDD7A2AEAQ36413210-738E31F3-137D-4FD7-8234-48813F0D372CQ36428234-AFFC4DEE-9BE7-43D3-A9AA-27DAF00F632DQ36472802-FD6A382E-7AB5-4219-8CB2-82EDA8E8C0C3Q36585532-2826854C-425F-42DA-991D-D4003C57C04EQ36748360-3A11DCED-3D8A-43EB-B410-20AE0E58222CQ37019488-C372098C-3404-4F4E-B7B9-B000F152838AQ37084635-5F27205B-E5C8-41FF-A6C7-F393EA773A75Q37157241-CF1011D9-80CC-4403-BB5E-92A68F873E66Q37469262-C811320A-5B39-4C96-BAFF-A9D94BB11B1EQ37478933-9B7D48A4-9067-46AE-87ED-F1D8A0C6BC88Q37636194-751571E0-7E9F-4597-8B1C-7ABB0B273CD3Q37687965-FF2017BF-99AB-410F-A8C0-71D2159C8744Q37793079-502DED3E-CD5C-4AF0-82DD-79958606CF74Q37807993-EE278F2C-AE9F-4E09-83B2-3881FB5788DDQ37896464-50D3F1BA-CCF2-4BB7-B170-A20B3D64F75EQ37900314-84EDF542-1299-4381-9A8A-61E6C50FEE10Q38012446-E6931CA5-C94F-4B1D-9825-68ACB76DBE7FQ38026945-DB0377DD-192D-4A21-B89B-53B0DD6C008EQ38037048-2B884210-1B9E-4F0D-B552-ABD40FC332B2Q38148788-7F31F65C-A3D3-42B7-BAFF-2FBFE963DBC6Q38235326-242593A9-60D7-46F0-9131-E249EA42B986Q38622404-1C86CEF0-0BC5-4F22-B7CA-5EA39FB2A4C6Q38879221-2DD8566E-E18D-42E9-B0FC-15E1B19FE290Q38955717-D9DB9B9E-6D49-42F5-900A-AF61DFB3E6EEQ38967041-799C79B6-A510-4A59-A8FD-439EB2793C52
P2860
Efficient siRNA delivery with non-viral polymeric vehicles.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Efficient siRNA delivery with non-viral polymeric vehicles.
@en
Efficient siRNA delivery with non-viral polymeric vehicles.
@nl
type
label
Efficient siRNA delivery with non-viral polymeric vehicles.
@en
Efficient siRNA delivery with non-viral polymeric vehicles.
@nl
prefLabel
Efficient siRNA delivery with non-viral polymeric vehicles.
@en
Efficient siRNA delivery with non-viral polymeric vehicles.
@nl
P1476
Efficient siRNA delivery with non-viral polymeric vehicles.
@en
P2093
Sung Wan Kim
Won Jong Kim
P304
P356
10.1007/S11095-008-9774-1
P577
2008-11-18T00:00:00Z